Related Experiment Video
Updated: Jan 26, 2026
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.8K
Pruritus in patients with amyopathic dermatomyositis
Dimitri Poddighe1, Zaure Mukusheva2, Maikesh Assylbekova1,2
11Department of Medicine, Nazarbayev University School of Medicine, Kerei-Zhanibek Str. 5/1, Astana, 010000 Kazakhstan.
Summary
Amyopathic dermatomyositis can be triggered by certain medications. One study linked omalizumab treatment to this condition, noting a paradoxical intense itching symptom in the patient.
Area of Science:
- Dermatology
- Rheumatology
- Clinical Pharmacology
Background:
- Amyopathic dermatomyositis is a rare autoimmune condition.
- Drug-induced cases of amyopathic dermatomyositis have been documented.
- Omalizumab is a biologic therapy used for allergic conditions.
Purpose of the Study:
- To report a case of amyopathic dermatomyositis potentially induced by omalizumab.
- To discuss the paradoxical symptom of pruritus in drug-induced amyopathic dermatomyositis.
Main Methods:
- Case report analysis.
- Literature review of drug-associated amyopathic dermatomyositis.
Main Results:
- A patient developed amyopathic dermatomyositis during omalizumab treatment.
- The patient experienced intense pruritus, a symptom also noted in other reported cases.
Conclusions:
- Omalizumab may be associated with the development of amyopathic dermatomyositis.
- Intense pruritus is a notable symptom in some drug-induced amyopathic dermatomyositis cases.
Related Concept Videos
01:13Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
01:15Drug Dosing: Geriatric Patients
229
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
229
01:21Drug Dosing: Obese Patients
238
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
193
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
193
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276